Can a Triple-Drug combo outsmart resistant leukemia?
Disease control
Not yet recruiting
This trial tests whether adding gilteritinib to the standard drugs azacitidine and venetoclax can help adults with a type of acute myeloid leukemia (AML) that has returned or stopped responding to prior treatment. Participants receive the three-drug combination in repeated 28-day…
Phase: PHASE2 • Sponsor: Florian Kuchenbauer • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC